The Interventional Oncology Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Interventional Oncology Devices Market?
The global market for interventional oncology devices has significantly expanded in past few years. The forecast suggests growth from $2.39 billion in 2024 to $2.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Interventional Oncology Devices Industry?
The Interventional Oncology Devices Global Market is projected to expand to a size of $3.34 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Interventional Oncology Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Interventional Oncology Devices Market?
The key drivers in the interventional oncology devices market are:
• Rise in the elderly population increasing the need for interventional oncology devices
• Growing preference for minimally invasive surgeries
• Increased funding for research and development increasing innovations
• High potential for growth in emerging economies with rising healthcare expenditure.
Global Market Segmentation: Identifying Major Interventional Oncology Devices Industry Segments
The interventional oncology devices market covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Pre-order the 2025 Interventional Oncology Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Interventional Oncology Devices Market?
The key trends in the interventional oncology devices market are:
• There is an ongoing focus on the development of advanced image-guided oncology devices.
• AI is increasingly being utilized in the development of innovative oncology devices.
• There is a growing trend towards the creation of innovative embolic devices to improve oncology procedures.
• Collaborations with other companies and research institutes for product development and innovation are becoming more prevalent.
Who Are the Top Competitors & Leading Players in the Interventional Oncology Devices Market?
Major companies in the interventional oncology devices market are:
• Boston Scientific Corporation
• Terumo Corporation
• Siemens Healthineers
• Sirtex Medical Limited
• Henlius
• Viant Medical
• AngioDynamics Inc.
• Pfizer
• Steris Applied Sterilization Technologies
• Dr.Reddys
• CapeRay
• Innovent Biologics
• Novartis AG
• Consonance
• ABLbio
• Adimmune
• Heraeus Medical
• Bioavlee
• Mediceena International
• Sinapi biomedical
• Olympus
• Freudenberg Medical
• Hisun Pharma
• Beijing ShuangLu Pharmaceuticals
• Edwards LifeSciences Corp
• Gulf Dent Trading
• LifeTech Scientific Corporation
• Biomerics
• Medtronic plc
• Dickinson & Company
• 3M Company
• DISA Vascular
• Johnson & Johnson
• Eurolab
• Koninklijke Philips
• Quantum Surgical
• Kyowa Hakko Kirin
• Viatris
• Nipro
• Zimmer Biomet Holdings
• Profound Medical
• Gedeon Richter
• Baxter
• Ti-TaMED
• Abbott Laboratories
• Cook Medical LLC
• Adavium Medical
• Autocam Medical
• Bio-Thera
• Stryker
• GE Healthcare
• Sonic Healthcare
• Medicem
• HealthTronics
• Bayer AG
• Intuitive Surgical Inc
• Aster DM Healthcare
• Danaher Corporation
• Varian Medical Systems Inc.
• Smileneo
• EDAP TMS S.A
• Fresenius Medical Care AG
• China Regenerative Medicine International
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the interventional oncology devices market in 2024
